Submission to PMPRB on their second phase of consultations for new guidelines
Release Date: 09/11/2024 Staff Reference: Joan WeirThe health insurance industry in Canada manages benefit plans for employers, plan sponsors and individuals and prescription drug reimbursement is a key part of almost all private benefit plans in Canada. We offer employers options that can help offset increasing cost pressures on drug plans and ensure their financial sustainability, while also supporting Canadians’ access to effective drug therapies.
Employers are looking for tools to help manage the rising cost of drugs today and for those innovative therapies currently under development. The work of the PMPRB to ensure prices are not excessive, is very important to helping employers continue to fund prescription drugs.
Private payers value the work of the PMPRB and appreciate the opportunity to provide comment into the Phase 2 Consultations.
